SCHEMBL2491374

SCHEMBL2491374

O=C1C2=C(CC(O)CC2)C(=O)c2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
CDC25B P30305 2/20 0.39
APAF1 O14727 2/20 0.39
TDP2 O95551 2/20 0.39
MAPT P10636 5/20 0.38
RAB9A P51151 3/20 0.38
S100A4 P26447 3/20 0.38
CES1 P23141 2/20 0.38
MAOA P21397 2/20 0.38
NPC1 O15118 2/20 0.38
POLB P06746 2/20 0.38
PTPRC P08575 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
MAPK1 P28482 2/20 0.38
CES2 O00748 1/20 0.38
TERT O14746 1/20 0.38
PLIN1 O60240 1/20 0.38
S1PR4 O95977 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31629274 0.90 MEN1 (0.44) MEN1KMT2ACDC25BAPAF1TDP2
SCHEMBL2492424 0.82 ESR2 (0.52) MAOABCL2MCL1
SCHEMBL23271865 0.78 KMT2A (0.39) MEN1KMT2ACDC25BAPAF1TDP2
SCHEMBL2490574 0.78 MEN1 (0.39) MEN1KMT2ACDC25BAPAF1TDP2
SCHEMBL30003093 0.78 MEN1 (0.39) MEN1KMT2ACDC25BAPAF1TDP2
SCHEMBL2491377 0.75 IDO1 (0.37) MEN1KMT2ACDC25BAPAF1TDP2
SCHEMBL31629183 0.75 MEN1 (0.44) MEN1KMT2ACDC25BAPAF1TDP2
SCHEMBL2493046 0.74 TP53 (0.47) MEN1KMT2ACDC25BAPAF1TDP2
SCHEMBL183347 0.74 LMNA (0.39) MEN1KMT2ACDC25BAPAF1TDP2
SCHEMBL38665414 0.74 TP53 (0.47) MEN1KMT2ACDC25BAPAF1TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-04-29 US disclosed
US-8344167-B2 Method for producing propylene oxide SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-01-01 US disclosed
EP-2173731-B1 METHOD FOR PRODUCING PROPYLENE OXIDE SUMITOMO CHEMICAL CO (JP) 2011-10-26 EP disclosed
US-20100197946-A1 METHOD FOR PRODUCING PROPYLENE OXIDE SUMITOMO CHEMICAL COMPANY , LIMITED 2010-08-05 US disclosed
EP-2173731-A2 METHOD FOR PRODUCING PROPYLENE OXIDE Sumitomo Chemical Company, Limited (JP) 2010-04-14 EP disclosed
WO-2009008493-A2 METHOD FOR PRODUCING PROPYLENE OXIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD PPOX, NOX4, CROCC MEN1 2943/4885KMT2A 2246/4885CDC25B 807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.